Active Ingredient: BUDESONIDE
Proprietary Name: BUDESONIDE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207367
Product Number: 001
Approval Date: Apr 7, 2017
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Prescription
Patent and Exclusivity Information